Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox 4 like 11 (DUX4L11) is a human pseudogene annotated in genome databases as related to the DUX4 gene family. Unlike functional DUX4 (which is a transcription factor with established biological and pathological roles, particularly in facioscapulohumeral muscular dystrophy), DUX4L11 has no evidence for protein product or biological activity. It does not serve a known biological role, participate in disease, nor act as a target for drugs or as a biomarker. Its annotation and nomenclature may sometimes cause confusion with functional DUX4 or DUX4-family transcription factors; care should be taken to distinguish pseudogenes from true therapeutic targets in research and drug development[1].
None documented; there are no identified mechanisms as DUX4L11 does not encode a validated protein target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox 4 like 11 (DUX4L11).